Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
Kosseifi
Semaan G
SG
Division of Hematology/Medical Oncology, Department of Internal Medicine, East Tennessee State University, Johnson City, USA. semaankosseifi@yahoo.com
Vyas
Bavna
B
Vyas
Harsha
H
Krishnaswamy
Guha
G
Smith
Steven
S
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002699:Chlorambucil / Q000009:adverse effects*; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D008297:Male; D012307:Risk Factors; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D005938:Glucocorticoids; D002699:Chlorambucil; D014740:Vidarabine; C024352:fludarabine